Arkolith/Insider Trading/CRBU/Form 4

Kanner Steven

Chief Scientific OfficerCaribou Biosciences, Inc. (CRBU) · full profile →Form 4 · filed Feb 8, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 6, 2024Option exercise(M)31K$2.69$82K354K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 6, 2024Option exercise(M)31K—$022K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001871131-24-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML